EPL Q1FY27: Growth Accelerates, Margins Hold Up, and Capital Efficiency Stays in Focus
Ask Iris
/
Frequently Asked Questions
Consolidated revenue from operations was INR 13,879 million in Q1 FY27, up 25.3% YoY from INR 11,079 million in Q1 FY26.
EBITDA was INR 2,612 million in Q1 FY27 versus INR 2,268 million in Q1 FY26, with reported EBITDA margin at 18.8% compared to 20.5% last year. The company also reported underlying EBITDA margin of 19.6%.
PAT declined 1.4% YoY to INR 986 million while PBT increased 10%. Management attributed the PAT decline to lapping a very low base effective tax rate in the prior year quarter.
The presentation shows Q1 FY27 tube revenue split as Oral Care 40%, Beauty and Cosmetics 40%, Pharma and Health 9%, and Others 5%. It also states Personal Care and beyond was 54% of total revenue.
EPL reported recyclable volumes at 44% of portfolio in Q1 FY27 (38% in FY26). It highlighted EcoVadis Platinum rating (top 1%) and recognition among the top about 2% companies on CDP Climate and Water A List 2025, and Zero Waste to Landfill certification for select Indian sites.
The company indicated the expected timeline for completion of the merger with Indovida as Q4 FY27.
ROCE was 18.5% in Q1 FY27. The company stated a target to increase ROCE from 18% to at least 25% by FY29.
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
